BrightEdge - American Cancer Society

🗓 Founded 2018👥 29 employees
Venture Capital and Private Equity Principals🌐 acsbrightedge.org
Website LinkedIn
BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our donor-funded ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone. 
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was BrightEdge - American Cancer Society founded?
BrightEdge - American Cancer Society was founded in 2018.
What industry is BrightEdge - American Cancer Society in?
BrightEdge - American Cancer Society operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.